References

Acion L, Peterson JJ, Temple S, et al: Probabilistic index: an intuitive non-parametric approach to measuring the size of treatment effects. Stat Med 25:591-602, 2006 [PubMed]

Altman DG, Schulz KF, Hoher D, et al: The revised CONSORT statement for reporting randomized trials: explanation and elaboration. CONSORT Group (Consolidated Standards of Reporting Trials). Ann Intern Med 134:663-694, 2001 [PubMed]

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000

Andersen PK, Borch-Johnsen K, Deckert T, et al: A Cox regression model for the relative mortality and its application to diabetes mellitus survival data. Biometrics 41:921-932, 1985 [PubMed]

Berger MPF: A comparison of efficiencies of longitudinal, mixed longitudinal, and cross-sectional designs. Journal of Educational Statistics 11:171-181, 1986

Blomqvist N: On the bias caused by regression toward the mean in studying the relation between change and the initial value. J Clin Periodontol 13:34-37, 1986

Borenstein M: The case for confidence intervals in controlled clinical trials. Control Clin Trials 15:411-428, 1994 [PubMed]

Borenstein M: Hypothesis testing and effect size estimation in clinical trials. Ann Allergy Asthma Immunol 78:5-16, 1997 [PubMed]

Borenstein M: The shift from significance testing to effect size estimation, in Comprehensive Clinical Psychology (Bellak AS, Hersen M, editors-in-chief), Vol 3: Research Methods (Schooler NR, volume editor). Burlington, MA, Elsevier Science, 1998, pp 319-349

Campbell DT, Kenny DA: A Primer on Regression Artifacts. New York, Guilford, 1999

Cohen J: The cost of dichotomization. Applied Psychological Measurement 7:249-253, 1983

Crabbe JC, Wahlsten D, Dudek BC: Genetics of mouse behavior: interactions with laboratory environment. Science 284:1670-1672, 1999 [PubMed]

Davis CE: The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol 104:493-498, 1976 [PubMed]

deLeeuw J, Kreft I: Random coefficient models for multilevel analysis. Journal of Educational Statistics 11:57-85, 1986

Freedman B: Equipoise and the ethics of clinical research. N Engl J Med 317:141-145, 1987 [PubMed]

Grissom RJ: Probability of the superior outcome of one treatment over another. J Appl Psychol 79:314-316, 1994

Grissom RJ, Kim JJ: Effect Sizes for Research: A Broad Practical Approach. Mahwah, NJ, Lawrence Erlbaum, 2005

Hoagwood K, Hibbs E, Brent D, et al: Introduction to the special section: efficacy and effectiveness in studies of child and adolescent psychotherapy. J Consult Clin Psychol 63:683-687, 1995 [PubMed]

Hill AB: Medical ethics and controlled trials. BMJ 1(5337):1043-1049, 1963 [PubMed]

Humphreys K, Weisner C: Use of exclusion criteria in selecting research patients and its effect on the generalizability of alcohol treatment outcome studies. Am J Psychiatry 157:588-594, 2000 [Full Text] [PubMed]

Humphreys K, Weingardt KR, Horst D, et al: Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98. Addiction 100:1249-1257, 2005 [PubMed]

Jones LV, Tukey JW: A sensible formulation of the significance test. Psychol Methods 5:411-414, 2000 [PubMed]

Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 562-563, 1958

Kemmler G, Hummer M, Widschwendter C, et al: Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs. Arch Gen Psychiatry 62:1305-1312, 2005 [PubMed]

Khan A, Warner HA, Brown WA: Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry 57:311-317, 2000[PubMed]

Khan A, Khan SR, Leventhal RM, et al: Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the Food and Drug Administration database. Am J Psychiatry 158:1449-1454, 2001 [Full Text] [PubMed]

Khan A, Kolts RL, Brodhead AE, et al: Suicide risk analysis among patients assigned to psychotropics and placebo. Psychopharmacol Bull 39:6-14, 2006 [PubMed]

Kraemer HC: To increase power in randomized clinical trials without increasing sample size. Psychopharmacol Bull 27:217-224, 1991 [PubMed]

Kraemer HC: Toward non-parametric and clinically meaningful moderators and mediators. Stat Med 27:1679-1692, 2008 [PubMed]

Kraemer HC, Blasey C: Centring in regression analysis: a strategy to prevent errors in statistical inference. Int J Methods Psychiatr Res 13:141-151, 2004 [PubMed]

Kraemer HC, Kupfer DJ: Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry 59:990-996, 2006 [PubMed]

Kraemer HC, Robinson TN: Are certain multicenter randomized clinical trial structures misleading clinical and policy decisions? Contemp Clin Trials 26:518-529, 2005 [PubMed]

Kraemer HC, Thiemann S: How Many Patients? Statistical Power Analysis in Research. Newbury Park, CA, Sage, 1987

Kraemer HC, Thiemann SA: A strategy to use "soft" data effectively in randomized clinical trials. J Consult Clin Psychol 57:148-154, 1989 [PubMed]

Kraemer HC, Frank E, Kupfer DJ: Moderators of treatment outcomes: clinical, research, and policy importance. JAMA 296:1286-1289, 2006 [PubMed]

Kraemer HC, Kiernan M, Essex MJ, et al: How and why criteria defining moderators and mediators differ between the Baron and Kenny and MacArthur approaches. Health Psychol 27:S101-S108, 2008

Leber P: The use of placebo control groups in the assessment of psychiatric drugs: an historical context. Biol Psychiatry 47:699-706, 2000 [PubMed]

Leber PD, Davis CS: Threats to the validity of clinical trials employing enrichment strategies for sample selection. Control Clin Trials 19:178-187, 1998 [PubMed]

MacCallum RC, Zhang S, Preacher KJ, et al: On the practice of dichotomization of quantitative variables. Psychol Methods 7:19-40, 2002 [PubMed]

Meehl PE: Theory testing in psychology and physics: a methodological paradox. Philos Sci 34:103-115, 1967

Meinert CL: Clinical Trials: Design, Conduct, and Analysis. New York, Oxford University Press, 1986

MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086, 1999

Rennie D: How to report randomized controlled trials: the CONSORT Statement. JAMA 276:649, 1996 [PubMed]

Rothman KJ, Michels KB: The continuing unethical use of placebo controls. N Engl J Med 331:394-398, 1994 [PubMed]

Rubin DB: Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol 66:688-701, 1974

Rubin DB: Teaching statistical inference for causal effects in experiments and observational studies. Journal of Educational and Behavioral Statistics 29:343-367, 2004

Rush AJ Jr, First MB, Blacker D (eds): Handbook of Psychiatric Measures, 2nd Edition. Washington, DC, American Psychiatric Publishing, 2008

Senn S: Regression to the mean. Stat Methods Med Res 6:99-102, 1997

Stigler SM: Regression towards the mean, historically considered. Stat Methods Med Res 6:103-114, 1997 [PubMed]

Storosum JG, Wohlfarth T, Gispen-de Wied CC, et al: Suicide risk in placebo-controlled trials of treatment for acute manic episode and prevention of manic-depressive episode. Am J Psychiatry 162:799-802, 2005 (Comment in: Am J Psychiatry 163:329, 2006)

Ware JH: Linear models for the analysis of longitudinal studies. Am Stat 39:95-101, 1985

Wen L, Badgett R, Cornell J: Number needed to treat: a descriptor for weighing therapeutic options. Am J Health Syst Pharm 62:2031-2036, 2005 [PubMed]

Copyright © 2009 American Psychiatric Publishing, Inc. All Rights Reserved.

Supplements For Diabetics

Supplements For Diabetics

All you need is a proper diet of fresh fruits and vegetables and get plenty of exercise and you'll be fine. Ever heard those words from your doctor? If that's all heshe recommends then you're missing out an important ingredient for health that he's not telling you. Fact is that you can adhere to the strictest diet, watch everything you eat and get the exercise of amarathon runner and still come down with diabetic complications. Diet, exercise and standard drug treatments simply aren't enough to help keep your diabetes under control.

Get My Free Ebook


Post a comment